Lundbeck / Tiefenbacher, Ratiopharm, Teva Pharma, Court of Appeal Brussels (Hof van Beroep te Brussel), 14 February 2012

search-result-placeholder.jpg

The Court of Appeal partially reversed the Brussels Commercial Court's decision invalidating Lundbeck's SPC for escitalopram, to the extent that it had immediate effect.

A summary of this case will be posted on http://www.KluwerIPCases.com

 

Comments (0)
Your email address will not be published.
Leave a Comment
Your email address will not be published.
Clear all
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community! Contact Editorial Guidelines
Image
AI Assistant on Kluwer IP Law's Manual IP
Image
Whitepaper

Book Ad List

Books
book1
Vissers Annotated European Patent Convention 2024 Edition
Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge
€105.00
AIPPI
Experimental Use and Bolar Exemptions
David Gilat, Charles A. Boulakia, Daphné Derouane & Ralph Nack
€190.00
book2
Annotated PCT
Malte Köllner
€160.00